25
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      International Journal of COPD (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on pathophysiological processes underlying Chronic Obstructive Pulmonary Disease (COPD) interventions, patient focused education, and self-management protocols. Sign up for email alerts here.

      39,063 Monthly downloads/views I 2.893 Impact Factor I 5.2 CiteScore I 1.16 Source Normalized Impact per Paper (SNIP) I 0.804 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          A seven-item prescreening questionnaire (gender, age, pack-years smoking, dyspnea, sputum, cough, previous spirometry data) was developed for COPD detection in the primary care setting (PUMA Study) of four Latin America countries.

          Objectives

          To validate the PUMA prescreening COPD questionnaire externally in two different populations (primary care and general).

          Methods

          The PUMA prescreening COPD questionnaire score was applied to subjects from the Hospital Maciel, Montevideo (primary care), case-finding program and the PLATINO population (general) using PUMA study inclusion criteria. Post-bronchodilator FEV 1/FVC <0.70 and lower limit of normal (LLN) criteria were used to define COPD. Area under the received operator curve (ROC AUC), sensitivity, specificity, predictive positive and negative values (PNV), number needed to treat (NNT), and best cut-points of the score were calculated.

          Results

          974 individuals from Hospital Maciel and 2512 from the PLATINO population were eligible, using post-bronchodilator FEV 1/FVC <0.70, 45.1% and 18.7% had COPD, respectively, and using LLN 38.4% and 15.4% had COPD, respectively. From Hospital Maciel (post-bronchodilator FEV 1/FVC <0.70), the best cut-point of ≥6 had moderate discriminatory power (ROC AUC 0.70), sensitivity 69.9%, specificity 62.1%, PNV 70.9%, and NNT of 3. The discriminatory power was 0.73 (ROC AUC) in the PLATINO population with three potential cut-points (Youden’s index): ≥3 (sensitivity 85.4%, specificity 46.9%), ≥4 (sensitivity 66.7%, specificity 66.5%), and ≥5 (sensitivity 51.5%, specificity 81.6%); the PNV at each cut-point was 93.3%, 89.9%, and 88.0%, respectively. The NNT was 5 for scores ≥3 and ≥4, and 4 for ≥5. The mean accuracy using the LLN for Hospital Maciel and PLATINO was 0.67 and 0.70, respectively.

          Conclusion

          External validation of the PUMA prescreening questionnaire in two Latin American populations (general and primary care) suggests moderate accuracy, similar to the original study in which the questionnaire was developed.

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

          American Journal of Respiratory and Critical Care Medicine, 195(5), 557-582
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities.

            This study aimed to determine the prevalence of chronic obstructive pulmonary disease (COPD) in Spain and identify the level of undiagnosed disease and its impact on health-related quality of life (HRQL) and activities of daily living (ADL). A population-based sample of 4274 adults aged 40-80 years was surveyed. They were invited to answer a questionnaire and undergo prebrochodilator and postbronchodilator spirometry. COPD was defined as a postbronchodilator FEV(1)/FVC (forced expiratory volume in 1 s/forced vital capacity) ratio of <0.70. For 3802 participants with good-quality postbronchodilator spirometry, the overall prevalence of COPD was 10.2% (95% CI 9.2% to 11.1%) and was higher in men (15.1%) than in women (5.6%). The prevalence of COPD stage II or higher was 4.4% (95%CI; 3.8%-5.1%). The prevalence of COPD increased with age and with cigarette smoking and was higher in those with a low educational level. A previous diagnosis of COPD was reported by only 27% of those with COPD. Diagnosed patients had more severe disease, higher cumulative tobacco consumption and more severely impaired HRQL compared with undiagnosed subjects. However, even patients with undiagnosed COPD stage I+ already showed impairment in HRQL and in some aspects of ADL compared with participants without COPD. The prevalence of COPD in individuals between 40 and 80 years of age in Spain is 10.2% and increases with age, tobacco consumption and lower educational levels. The rate of diagnosised COPD is very high and undiagnosed individuals with COPD already have a significant impairment in HRQL and ADL.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Determinants of underdiagnosis of COPD in national and international surveys.

              COPD ranks within the top three causes of mortality in the global burden of disease, yet it remains largely underdiagnosed. We assessed the underdiagnosis of COPD and its determinants in national and international surveys of general populations.
                Bookmark

                Author and article information

                Contributors
                On behalf of : On behalf of the PLATINO team
                Journal
                Int J Chron Obstruct Pulmon Dis
                Int J Chron Obstruct Pulmon Dis
                COPD
                copd
                International Journal of Chronic Obstructive Pulmonary Disease
                Dove
                1176-9106
                1178-2005
                26 August 2019
                2019
                : 14
                : 1901-1911
                Affiliations
                [1 ]Department of Pulmonary, Universidad de la República , Montevideo, Uruguay
                [2 ]Department of Pulmonary, Universidad Central de Venezuela , Caracas, Venezuela
                [3 ]Department of Pulmonary, Federal University of Pelotas , Pelotas, Brazil
                [4 ]Department of Pulmonary, AstraZeneca , San Jose, Costa Rica
                Author notes
                Correspondence: Maria Victorina Lopez VarelaUniversidad de la República, Facultad de Medicina, Hospital Maciel , Montevideo11200, UruguayTel +598 9 961 7256Email victorina.lopezvarela@gmail.com
                Article
                206250
                10.2147/COPD.S206250
                6717054
                31692595
                2a9224eb-867d-40b7-9f60-90869ccd57c1
                © 2019 Lopez Varela et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 21 February 2019
                : 17 May 2019
                Page count
                Figures: 3, Tables: 4, References: 24, Pages: 11
                Categories
                Original Research

                Respiratory medicine
                copd,diagnostic questionnaire,primary care,validation,latin america
                Respiratory medicine
                copd, diagnostic questionnaire, primary care, validation, latin america

                Comments

                Comment on this article